153 related articles for article (PubMed ID: 36992655)
1. Diagnostic and predictive value of liquid biopsy-derived exosome miR-21 for breast cancer: a systematic review and meta-analysis.
Wang M; Wang Y; Tian X; Wang Q; Huang H; Lu X; Qi M; Cao X; Lei J
Expert Rev Mol Diagn; 2023 Apr; 23(4):315-324. PubMed ID: 36992655
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of serum miR-21 in patients with ovarian cancer: a systematic review and meta-analysis.
Qiu L; Weng G
J Ovarian Res; 2022 May; 15(1):51. PubMed ID: 35501921
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
Hillyar CR; Kanabar SS; Pufal KR; Saw Hee JL; Lawson AW; Mohamed Y; Jasim D; Reed L; Rallis KS; Nibber A
Epigenomics; 2023 May; 15(10):593-613. PubMed ID: 37535320
[TBL] [Abstract][Full Text] [Related]
9. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers.
Shen L; Wan Z; Ma Y; Wu L; Liu F; Zang H; Xin S
Tumour Biol; 2015 Mar; 36(3):1993-2005. PubMed ID: 25431259
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
12. Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis.
Yang B; Xiong WY; Hou HJ; Xu Q; Cai XL; Zeng TX; Ha XQ
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115208
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
Sur D; Advani S; Braithwaite D
Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the diagnostic value of exosomal miR-21 as a biomarker for the prediction of cancer.
Liu F; Mao H; Chai S; Mao H
J Clin Lab Anal; 2021 Oct; 35(10):e23956. PubMed ID: 34492742
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: A systematic evaluation and meta-analysis.
Hong F; Li N; Feng Z; Zheng Y; Zhu C; Zhang F
Asian J Surg; 2023 Nov; 46(11):4727-4736. PubMed ID: 37301624
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 as a potential biomarker for detecting esophageal carcinoma in Asian populations: a meta-analysis.
Han Z; Pan L; Lu B; Zhu H
PeerJ; 2022; 10():e14048. PubMed ID: 36199284
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.
Ren J; Kuang TH; Chen J; Yang JW; Liu YX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):120-130. PubMed ID: 28121346
[TBL] [Abstract][Full Text] [Related]
19. Value of miR-21 levels as potential biomarkers in the early diagnosis of hepatocellular carcinoma：a meta-analysis.
Zhang H; Ding R; Chen D
Biomarkers; 2021 Nov; 26(7):586-597. PubMed ID: 34266326
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA-195 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Liu Y; Tang D; Zheng S; Su R; Tang Y
Int J Clin Exp Pathol; 2019; 12(11):3982-3991. PubMed ID: 31933794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
